Research Topics
Genomes and Genes | Beka SolomonSummaryAffiliation: Tel Aviv University Country: Israel Publications
| Collaborators
|
Detail Information
Publications
Filamentous phage as vector-mediated antibody delivery to the brainDan Frenkel
Department of Molecular Microbiology and Biotechnology, The George S. Wise Faculty of Life Sciences, Tel Aviv University, Ramat Aviv, Tel Aviv 69978, Israel
Proc Natl Acad Sci U S A 99:5675-9. 2002..The ability to image A beta deposits in vivo would arguably provide the most useful diagnostic and monitoring test for early diagnosis of Alzheimer's disease...
Alzheimer's disease immunotherapy: from in vitro amyloid immunomodulation to in vivo vaccinationBeka Solomon
Department of Molecular Microbiology and Biotechnology, George S Wise Faculty of Life Sciences, Tel Aviv University, Ramat Aviv, Tel Aviv 69978, Israel
J Alzheimers Dis 9:433-8. 2006....
Immunotherapy against APP beta-secretase cleavage site improves cognitive function and reduces neuroinflammation in Tg2576 mice without a significant effect on brain abeta levelsIdan Rakover
Department of Molecular Microbiology and Biotechnology, George S Wise Faculty of Life Sciences, Tel Aviv University, Ramat Aviv, Tel Aviv, Israel
Neurodegener Dis 4:392-402. 2007....
Immunotherapy for Alzheimer's disease: attacking amyloid-beta from the insideMichal Arbel
Department of Molecular Microbiology and Biotechnology, George S Wise Faculty of Life Sciences, Tel Aviv University, Ramat Aviv, Tel Aviv 69978, Israel
Trends Immunol 28:511-3. 2007..This work suggests novel avenues for the immunotherapy of Alzheimer's disease...
Intravenous immunoglobulin and Alzheimer's disease immunotherapyBeka Solomon
Department of Molecular Microbiology and Biotechnology, George S Wise Faculty of Life Sciences, Tel Aviv University, Ramat Aviv 69978, Tel Aviv, Israel
Curr Opin Mol Ther 9:79-85. 2007....
Immunotherapeutic strategies for Alzheimer's disease treatmentBeka Solomon
Department of Molecular Microbiology and Biotechnology, George S Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel
ScientificWorldJournal 9:909-19. 2009..Immunotherapy represents fascinating ways to test the amyloid hypothesis and offers genuine opportunities for AD treatment, but requires careful antigen and antibody selection to maximize efficacy and minimize adverse events...
Active immunization against Alzheimer's beta-amyloid peptide using phage display technologyBeka Solomon
Department of Molecular Microbiology and Biotechnology, George S Wise Faculty of Life Sciences, Tel Aviv University, Ramat Aviv, Tel Aviv 69978, Israel
Vaccine 25:3053-6. 2007..This immunization procedure led to improvement in cognitive functions and alleviated amyloid pathology in a transgenic mouse (Tg) model of AD...
Filamentous bacteriophage as a novel therapeutic tool for Alzheimer's disease treatmentBeka Solomon
Department of Molecular Microbiology and Biotechnology, George S Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel
J Alzheimers Dis 15:193-8. 2008..The feasibility of these novel strategies for production and targeting of anti-aggregating antibodies against Abeta plaques to disease affected regions in the CNS may have clinical potential for treatment of Alzheimer's disease...
Immunological approaches for amyloid-beta clearance toward treatment for Alzheimer's diseaseBeka Solomon
Department of Molecular Microbiology and Biotechnology, George S Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel
Rejuvenation Res 11:349-57. 2008..Antibodies generated with the first-generation vaccine might not have the desired therapeutic properties to target the "correct" mechanism, however, new immunological approaches are now under consideration...
Clinical immunologic approaches for the treatment of Alzheimer's diseaseBeka Solomon
George S Wise Faculty of Life Sciences, Department of Molecular Microbiology and Biotechnology, Tel Aviv University, Ramat Aviv, Tel Aviv, Israel
Expert Opin Investig Drugs 16:819-28. 2007....
Antibody-mediated immunotherapy for Alzheimer's diseaseBeka Solomon
Tel Aviv University, George S Wise Faculty of Life Sciences, Department of Molecular Microbiology and Biotechnology, Ramat Aviv, Tel Aviv 69978, Israel
Curr Opin Investig Drugs 8:519-24. 2007..Clearly, future therapeutic approaches for Alzheimer's disease depend on increased research into the various mechanisms of immunotherapy to successfully clear Abeta peptides...
Beta-amyloidbased immunotherapy as a treatment of Alzheimers diseaseBeka Solomon
Department of Molecular Microbiology and Biotechnology, George S Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel
Drugs Today (Barc) 43:333-42. 2007..The data presented support the hypothesis that beta-amyloid peptide plays a central role in Alzheimer's disease, and antibodies which modulate beta-amyloid conformation may lead to immunotherapy of the disease...
Alzheimer's disease and immunotherapyBeka Solomon
Department of Molecular Microbiology and Biotechnology, George S Wise Faculty of Life Sciences, Tel Aviv University, Ramat Aviv, Tel Aviv, P O Box 69978, Israel
Curr Alzheimer Res 1:149-63. 2004..Immunotherapy represents fascinating ways to test the amyloid hypothesis and offers genuine opportunities for AD treatment, but requires careful antigen and antibody selection to maximize efficacy and minimize adverse events...
Generation of anti-beta-amyloid antibodies via phage display technology towards Alzheimer's disease vaccinationBeka Solomon
Department of Molecular Microbiology and Biotechnology, George S Wise Faculty of Life Sciences, Tel Aviv University, Ramat Aviv, Tel Aviv 69978, Israel
Vaccine 23:2327-30. 2005..Performance of such antigens opens up possibilities for development of an efficient, long-lasting immunization procedure for treatment of Alzheimer's disease...
Immunological approach for the treatment of Alzheimer's diseaseBeka Solomon
Department of Molecular Microbiology and Biotechnology, Faculty of Life Sciences, Tel Aviv University, Ramat Aviv, Tel Aviv 69978, Israel
J Mol Neurosci 20:283-6. 2003..These data support the hypotheses that AbetaP plays a central role in AD, and site-directed antibodies that modulate AbetaP conformation might lead toward immunotherapy of the disease...
Anti-aggregating antibodies, a new approach towards treatment of conformational diseasesBeka Solomon
Department of Molecular Microbiology Biotechnology, The George S Wise Faculty of Life Sciences, Tel Aviv University, Ramat Aviv, Tel Aviv, 69978, Israel
Curr Med Chem 9:1737-49. 2002....
Towards Alzheimer's disease vaccinationBeka Solomon
Department of Molecular Microbiology Biotechnology, Faculty of Life Sciences, Tel Aviv University, Ramat Aviv, Tel Aviv, 69978, Israel
Mini Rev Med Chem 2:85-92. 2002....
Immunotherapy for Alzheimer's diseaseBeka Solomon
Department of Molecular Microbiology and Biotechnology, George S Wise Faculty of Life Sciences, Tel Aviv University, Ramat Aviv, Tel Aviv, Israel
Neuropharmacology 59:303-9. 2010..The renewed human phase clinical trials toward improved immunotherapeutic strategies which maintain the beneficial effects without adverse side effects are under further evaluation...
Immunological approaches as therapy for Alzheimer's diseaseBeka Solomon
Department of Molecular Microbiology and Biotechnology, George S Wise Faculty of Life Sciences, Tel Aviv University, Ramat Aviv, Tel Aviv 69978, Israel
Expert Opin Biol Ther 2:907-17. 2002..These data support the hypothesis that AbetaP plays a central role in AD and antibodies which modulate Abeta conformation may lead to immunotherapy of the disease...
EFRH-phage immunization of Alzheimer's disease animal model improves behavioral performance in Morris water maze trialsVered Lavie
Department of Molecular Microbiology and Biotechnology, George S. Wise Faculty of Life Sciences, Tel-Aviv University, Ramat Aviv, Tel-Aviv, Israel 69978
J Mol Neurosci 24:105-13. 2004....
Reduction of beta-amyloid plaques in brain of transgenic mouse model of Alzheimer's disease by EFRH-phage immunizationDan Frenkel
Department of Molecular Microbiology and Biotechnology, The George S Wise Faculty of Life Sciences, Tel-Aviv University, Ramat Aviv, Tel-Aviv 69978, Israel
Vaccine 21:1060-5. 2003..The immunization provoked a considerable reduction in the number of Abeta amyloid plaques in the brain of the transgenic mice and may serve as the basis for anti-Abeta vaccine...
Stimulation of endogenous neurogenesis by anti-EFRH immunization in a transgenic mouse model of Alzheimer's diseaseMaria Becker
Department of Molecular Microbiology and Biotechnology, George S Wise Faculty of Life Sciences, Tel Aviv University, Ramat Aviv, Tel Aviv 69978, Israel
Proc Natl Acad Sci U S A 104:1691-6. 2007....
Inhibition of amyloid precursor protein processing by beta-secretase through site-directed antibodiesMichal Arbel
Department of Molecular Microbiology and Biotechnology, George S. Wise Faculty of Life Sciences, Tel Aviv University, Ramat Aviv, Tel Aviv 69978, Israel
Proc Natl Acad Sci U S A 102:7718-23. 2005..Indeed, blocking of the beta-secretase site by these antibodies interfered with BACE activity and inhibited both intracellular and extracellular AbetaP formation in these cells...
Intravenous immunoglobulin enhances the clearance of fibrillar amyloid-beta peptideGili Istrin
Department of Molecular Microbiology and Biotechnology, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel
J Neurosci Res 84:434-43. 2006..Thus, several mechanisms can be considered when examining the effects of IVIg. Our work supports the hypothesis that IVIg interferes by more than one mechanism in clearing AbetaP from the brains of Alzheimer's patients...
Deglycosylation of anti-beta amyloid antibodies inhibits microglia activation in BV-2 cellular modelSabina Rebe
Department of Molecular Microbiology and Biotechnology, George S. Wise Faculty of Life Sciences, Tel-Aviv University, Ramat Aviv, Tel Aviv, Israel
Am J Alzheimers Dis Other Demen 20:303-13. 2005..These data suggest that deglycosylation of anti-Abeta antibodies before in vivo administration might prevent microglial overactivation, thus reducing the risk of neuroinflammatory response during passive immunization...
Generation of anti-beta-amyloid antibodies via phage display technologyDan Frenkel
Department of Molecular Microbiology and Biotechnology, George S. Wise Faculty of Life Sciences, Tel-Aviv University, Ramat Aviv, Tel-Aviv 69978, Israel
Vaccine 22:2505-8. 2004..EFRH-phage immunization of a transgenic mouse model of Alzheimer's disease evokes antibodies able to dissolve already formed beta-amyloid plaques, suggesting that they could become a therapeutic approach in treatment of the disease...
Antigen-specific therapy of EAE via intranasal delivery of filamentous phage displaying a myelin immunodominant epitopeIdan S Rakover
Department of Molecular Microbiology and Biotechnology, George S Wise Faculty of Life Sciences, Tel Aviv University, Ramat Aviv, Tel Aviv, Israel
J Neuroimmunol 225:68-76. 2010....
Beneficial effect of antibodies against β- secretase cleavage site of APP on Alzheimer's-like pathology in triple-transgenic miceInna Rabinovich-Nikitin
Department of Molecular Microbiology and Biotechnology, George S Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel
PLoS ONE 7:e46650. 2012....
A novel immunotherapy for Alzheimer's disease: antibodies against the beta-secretase cleavage site of APPMichal Arbel
Department of Molecular Microbiology and Biotechnology, George S Wise Faculty of Life Sciences, Tel Aviv University, Ramat Aviv, Tel Aviv, Israel
Curr Alzheimer Res 4:437-45. 2007..The relevance of intra-neuronal accumulation of mainly Abeta42 as an early event in AD pathogenesis suggests that this approach may be applicable as a novel therapeutic strategy in AD treatment...
Generation of antibodies against prion protein in wild-type mice via helix 1 peptide immunizationMichal Arbel
Department of Molecular Microbiology and Biotechnology, George S. Wise Faculty of Life Sciences, Tel-Aviv University, Ramat Aviv, Tel-Aviv 69978, Israel
J Neuroimmunol 144:38-45. 2003..The generated antibodies recognize the whole prion protein with a high binding constant and the established protocol may lead to an active immunization towards therapeutics of prion disease...
Filamentous phages reduce alpha-synuclein oligomerization in the membrane fraction of SH-SY5Y cellsHemi Dimant
Department of Molecular Microbiology and Biotechnology, George S Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel
Neurodegener Dis 7:203-5. 2010..Much effort is dedicated to prevent and dissolve AS aggregates, specifically AS oligomers and protofibrils, which are thought to be the more toxic form of aggregates...
Single chain antibody against the common epitope of mutant p53 restores wild-type activity to mutant p53 proteinSara Orgad
Department of Molecular Microbiology and Biotechnology, Tel Aviv University, Israel
FEBS Lett 579:5609-15. 2005..These findings suggest that the scFv restores wild-type properties to mutant p53...
TAR1, a human anti-p53 single-chain antibody, restores tumor suppressor function to mutant p53 variantsSara Orgad
Department of Molecular Microbiology and Biotechnology, Tel Aviv University, Ramat Aviv, Tel Aviv, Israel
J Immunother 33:146-54. 2010..Thus, it may be considered as a potential candidate for anticancer treatment, targeting tumors with mutant p53...
Inhibition of amyloid precursor protein beta-secretase cleavage site affects survival and motor functions of amyotrophic lateral sclerosis transgenic micePolina Rabinovich-Toidman
Department of Molecular Microbiology and Biotechnology, George S Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel
Neurodegener Dis 10:30-3. 2012..The APP cleavage products--soluble APP-β (sAPPβ), amyloidogenic Aβ, and amino-terminal fragment N-APP--mediate a reduction in synaptic transmission, synaptic loss, neurite retraction and, ultimately, programmed cell death...
Modulation effect of filamentous phage on alpha-synuclein aggregationHemi Dimant
Department of Molecular Microbiology and Biotechnology, George S Wise Faculty of Life Sciences, Tel Aviv University, Ramat Aviv, Tel Aviv 69978, Israel
Biochem Biophys Res Commun 383:491-6. 2009..Data presented here show reduced levels of AS soluble aggregates in phage treated cells compared to non-treated cells, suggesting new therapeutics for PD...
Immunomodulation of AβPP processing alleviates amyloid-β-related pathology in Alzheimer's disease transgenic miceMichal Arbel-Ornath
Department of Molecular Microbiology and Biotechnology, George S Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel
J Alzheimers Dis 22:469-82. 2010....
Antibodies to beta-amyloid decrease the blood-to-brain transfer of beta-amyloid peptideWeihong Pan
Veterans Affairs Medical Center and Department of Medicine, Tulane University School of Medicine, New Orleans, Louisiana 70112, USA
Exp Biol Med (Maywood) 227:609-15. 2002..The presence of mAbmc1 also caused significant reduction of the influx of Abeta into the brain after perfusion. Therefore, effective antibodies to Abeta can reduce the influx of Abeta(1-40) into the brain...
A neuroimmunologist's perspective on Alzheimer's disease therapyBeka Solomon
Expert Rev Neurother 7:439-41. 2007
